Cognition Therapeutics, Inc. (CGTX) Analyst Estimates Quarterly - Discounting Cash Flows

Cognition Therapeutics, Inc. (CGTX) Analyst Estimates Quarterly - Discounting Cash Flows

Cognition Therapeutics, Inc.

CGTX (NASDAQ)

(%)

Financials
Cognition Therapeutics, Inc. Analyst Estimates Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2026 09-30	2026 06-30	2026 03-30	2025 12-30	2025 09-30
Number of Analysts	1234				0	0
Estimated Revenue
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EBITDA
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EBIT
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated Net Income
Low	1234				-7.05	-9.02
Average	1234				-6.04	-7.02
High	1234				-5.03	-6.01
Estimated SGA Expenses
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EPS
Low	1234				-0.09	-0.116
Average	1234				-0.077	-0.09
High	1234				-0.065	-0.077